Arrowhead Research | Capitale Sociale E Riserve





Capitale Sociale E Riserve Cambiamento Data
Agios Pharmaceuticals USD 1.19B 91.22M 2025-12
Alnylam Pharmaceuticals USD 789.18M 555.28M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Incyte USD 5.17B 516.28M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
Ligand Pharmaceuticals USD 950.17M 121.64M 2025-09
Merck USD 51.85B 2.79B 2025-09
Moderna USD 8.65B 680M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Novartis USD 44.75B 2.7B 2025-09
Sarepta Therapeutics USD 1.32B 37.26M 2025-09
TG Therapeutics USD 607.22M 330.79M 2025-09
Ultragenyx Pharmaceutical USD 9.16M 142.13M 2025-09
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12
Xencor USD 635.59M 10.27M 2025-12


Arrowhead Research Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.